Pivotal Trial Expected to Enroll More Than 140 Patients With Moderate to Severe Congenital Ichthyosis at Leading Research Centers in the U.S., Canada, Italy, France, and Germany BASKING RIDGE, NJ, June 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a… Read More..

PRINCETON, N.J., June 23, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today 100% protection of non-human primates (NHPs) against lethal Marburg marburgvirus (MARV) challenge using… Read More..

Founder Steve Morris, appointed Chief Platform Officer to steer Bubblr's platform and data privacy efforts  NEW YORK, NY, June 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire– Bubblr Inc., (OTC PINK: BBLR), ("Bubblr" or the "Company"), the company making ethically-based Web3 development tools more accessible to programmers, companies and investors via… Read More..